Nyxoah (NYXH) Free Cash Flow Growth (1y) (2022 - 2026)
Nyxoah (NYXH) Free Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 69.33% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -31.57% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -28.80% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -20.60% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 594.25% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -20.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 144.07% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 432.60% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 5.85% |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.97% |
| Mar 31, 2026 | 29.55% |
| Dec 31, 2025 | -854.35% |
| Sep 30, 2025 | 832.80% |
| Jun 30, 2025 | -57.46% |
| Mar 31, 2025 | 45.34% |
| Dec 31, 2024 | 81.70% |
| Sep 30, 2024 | -123.78% |
| Jun 30, 2024 | -6.41% |
| Mar 31, 2024 | 16.50% |
| Dec 31, 2023 | -599.69% |
| Sep 30, 2023 | 807.36% |
| Jun 30, 2023 | -124.90% |
| Mar 31, 2023 | 81.57% |
| Dec 31, 2022 | -38.53% |
| Sep 30, 2022 | 71.99% |
| Jun 30, 2022 | -202.26% |
| Mar 31, 2022 | 234.57% |